Purchase Order N3239823P0706
Award Date 9/21/23
Potential Completion Date 9/20/24
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a $28,100 firm fixed-price purchase order to Creative Biolabs Inc., a for-profit biotechnology and pharmaceutical services company, for ADC Production Services. This award is associated with a sole source Special Notice issued by the Naval Medical Research Command (NMRC) for antibody-drug conjugate (ADC) services, including IgG purification, linker payload synthesis and conjugation, and standard product quality...
- The U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) awarded a Firm Fixed Price Purchase Order contract to LakePharma, Inc., a minority-owned, for-profit small business, to provide custom gene synthesis, baculovirus generation, and protein expression and purification services. The contract has a ceiling value of $15,419.00 and was awarded on September 29, 2018, with a period of performance through September 30, 2019. The services are focused on supporting BUMED's medical...
- The Bureau of Medicine and Surgery (BUMED), the medical branch of the Department of the Navy, awarded a $105,375 firm fixed-price purchase order to Olink Proteomics Inc. on August 19, 2024, for the Olink Signature Q100 system and related proteomics services. The award was issued as a sole source contract based on a Special Notice posted by the Naval Medical Research Command (NMRC) in July 2024. This contract supports NMRC's research initiatives focused on identifying biomarkers related to...
- The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
- The U.S. Navy's Bureau of Medicine and Surgery awarded Illumina, Inc. a fixed-price delivery order valued at $82,029.96 for NovaSeq 6000 S4 Reagent Kit V1.5, with an ultimate completion date of June 16, 2025. The contract, awarded on June 6, 2025, involves fixed-price pricing with economic price adjustment provisions and carries no set-aside designation. Performance will take place in Frederick, Maryland, where the reagent kits will support the Navy's genomic sequencing and analysis...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $126,350 firm fixed price purchase order to One Lambda, Inc., a for-profit manufacturer of medical testing reagents, kits, and related products. The contract, designated #DB-244, AB 3730XL - 96 GENETRIC ANALYZER, does not have a set-aside designation and was completed on September 21, 2017. One Lambda, Inc. is a subsidiary of the Thermo Electron Corporation Financial Services Division, which has previously provided scientific...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $70,622.20 firm fixed-price purchase order to Genscript USA Inc. on August 5, 2020, for customized RAB (Recombinant Antibody) expression synthesis under the FY26 UDO Initiative. The contract, which was not designated as a set-aside, had an ultimate completion date of September 28, 2020, and represents a rapid procurement cycle with posting on July 24, 2020, and award on August 4, 2020. Performance of work is located at...
- This is a $3,995,959.00 cost-plus-fixed-fee delivery order contract awarded by the Naval Sea Systems Command (NAVSEA) to The Johns Hopkins University Applied Physics Laboratory LLC (APL), a university-affiliated research center. The contract is for a project called "NAVY OPERATIONAL GENOMICS RESEARCH ENGINEERING" with a completion date of September 30, 2024. There was no set-aside used for this award. As a subcontractor, Exone Operating, LLC, a specialist in additive manufacturing,...